
Company valuation, historical trends, and peer comparisons.
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 569.01B. This represents a change of 19.69% compared to the average of 475.39B of the last 4 quarters.
The mean historical Enterprise Value of AbbVie Inc. over the last ten years is 272.22B. The current 569.01B Enterprise Value has changed 109.03% with respect to the historical average. Over the past ten years (40 quarters), ABBV.TO's Enterprise Value was at its highest in in the June 2026 quarter at 509.91B. The Enterprise Value was at its lowest in in the December 2016 quarter at 131.47B.
Average
272.22B
Median
282.36B
Minimum
133.31B
Maximum
469.18B
Discovering the peaks and valleys of AbbVie Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.51%
Maximum Annual Enterprise Value = 469.18B
Minimum Annual Increase = -9.59%
Minimum Annual Enterprise Value = 133.31B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 469.18B | 24.56% |
| 2024 | 376.67B | 17.24% |
| 2023 | 321.29B | -5.83% |
| 2022 | 341.20B | 10.96% |
| 2021 | 307.49B | 19.54% |
| 2020 | 257.23B | 62.51% |
| 2019 | 158.29B | -9.59% |
| 2018 | 175.09B | -4.02% |
| 2017 | 182.41B | 36.83% |
| 2016 | 133.31B | 11.52% |
The current Enterprise Value of AbbVie Inc. (ABBV.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
389.05B
5-year avg
363.17B
10-year avg
272.22B
AbbVie Inc.’s Enterprise Value is less than Eli Lilly and Company (1.24T), greater than Gilead Sciences, Inc. (0), greater than Roche Holding AG (296.11B), greater than Merck & Co., Inc. (405.46B), greater than Pfizer Inc. (233.38B), greater than Novartis AG (336.73B), greater than Amgen Inc. (280.79B), greater than Sanofi (106.03B), less than Johnson & Johnson (662.81B), greater than AstraZeneca PLC (293.48B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.24T | $1.57T | |
| 0 | $270.73B | |
| 296.11B | $21.45B | |
| 405.46B | $79.57B | |
| 233.38B | $75.92B | |
| 336.73B | $54.39B | |
| 280.79B | $17.54B | |
| 106.03B | $22.83B | |
| 662.81B | $833.00B | |
| 293.48B | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AbbVie Inc.'s Enterprise Value?
What is the highest Enterprise Value for AbbVie Inc. (ABBV.TO)?
What is the 3-year average Enterprise Value for AbbVie Inc. (ABBV.TO)?
What is the 5-year average Enterprise Value for AbbVie Inc. (ABBV.TO)?
How does the current Enterprise Value for AbbVie Inc. (ABBV.TO) compare to its historical average?